I don't know if its realistic, but its been done....Stellar Biotech went from the Venture to the Nasdaq after consolidating.

At 1:5 the USD PPS for RVXCF would be up in and around $7.50, well within listing standards. The roughly 175 million shares would be reduced down to just 35 million.

And then...and this might be the reason its not realistic.  Then I'd like to see DM try to engage an investment banking firm and have a share offering.  If an investment bank could be persuaded to underwrite an offering at $7.50 for 10 million shares that would raise $75 million USD less fees....which coupled with whatever is left over from Hepa's $87 million investment and the ROFR deal with Hepa USA, it should be enough to at least get BETonMACE to the finish line with cash left over.